Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Julphar
Covington
Moodys
US Army

Generated: April 24, 2019

DrugPatentWatch Database Preview

NORVASC Drug Profile

« Back to Dashboard

When do Norvasc patents expire, and when can generic versions of Norvasc launch?

Norvasc is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in NORVASC is amlodipine besylate. There are fifty drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the amlodipine besylate profile page.

Drug patent expirations by year for NORVASC
Pharmacology for NORVASC
Synonyms for NORVASC
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
2-(2-aminoethoxy)methyl-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid O3-ethyl ester O5-methyl ester
2-[(2-Aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5- pyridinedicarboxylic acid 3-ethyl 5-methyl ester benzene sulfonate, Norvasc
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methylester
2-[2-Aminoethoxymethyl]-3-ethoxycarbonyl-4-(2-chlorophenyl)-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
2-[2-aminoethoxymethyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate (C6H5SO3H)
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate benzene sulfonate
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methylester, (+/-)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl (+-)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-ethyl5-methylester
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3,5-pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, benzene sulfonate
3,5-pyridinedicarboxylicacid,1,4-dihydro-2-((2-aminoethoxy)methyl)-4-(2-chlor
50A429
88150-42-9
88150-47-4 (maleate (1:1))
A800681
AB0008128
AB01209618-01
AB01274726_03
AB01274726_04
AB01274726_05
AB01274726-01
AB01274726-02
AB2000364
ABP000734
AC-4535
AC1L1D26
AC1Q32ZS
AK163198
AKOS015843475
ALBB-027270
Amlocard
Amlodipin
amlodipine
amlodipine (NORVASC)
Amlodipine (USAN/INN)
Amlodipine [INN:BAN]
AMLODIPINE BASE
Amlodipine Free Base
Amlodipine/
Amlodipino
Amlodipino [Spanish]
Amlodipinum
Amlodipinum [Latin]
Amlodis
Amlor
Amvaz
AN-11880
AN-14382
API0005963
AS-13747
AX8042079
BBL023710
BC203909
BCP02420
BCP9000295
BCPP000403
BDBM50088383
BG0034
BIDD:GT0810
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BRD-A22032524-074-04-0
BSPBio_002727
C06825
C20H25ClN2O5
CA0134
Caduet
CCG-101157
CCG-220414
CHEBI:2668
CHEMBL1491
CHEMBL3211346
CHEMBL3304444
Copalia (amlodipine + valsartan)
Coroval
CPD000469198
CPD004727074
CS-2357
D07450
DB00381
DTXSID7022596
EC 425-820-1
FT-0602653
GTPL6981
HMS2052N03
HMS2089H07
HMS2231K08
HMS3370G17
HMS3394N03
HMS3651I04
HMS3713C10
HSDB 7079
HTIQEAQVCYTUBX-UHFFFAOYSA-N
HY-B0317
I14-0798
Istin
Istin;Norvasc;Caduet;Norvasc
J10237
K577
KBio3_001947
KBioGR_001643
KS-00000L67
Lipinox
LS-131183
MCULE-8264151664
methyl ethyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
MFCD00864687
MLS001401409
MolPort-001-792-963
NC00407
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
NCGC00165957-04
NCGC00165957-05
NCGC00165957-07
Norvasc (TN)
O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
O3-ethyl O5-methyl 2-(2-azanylethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
R3932
Racemic Amlodipine
s1905
SAM001246705
SC-15164
SC-16184
SC-16480
SCHEMBL26478
SMR000469198
SPBio_000351
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
SR-05000001461
SR-05000001461-3
SR-05000001461-4
SR-05000001461-5
ST24045949
STL356053
SW220228-1
UK-4834011
W-3152
ZX-AN025779

US Patents and Regulatory Information for NORVASC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-001 Jul 31, 1992 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-002 Jul 31, 1992 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-003 Jul 31, 1992 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for NORVASC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-002 Jul 31, 1992 ➤ Sign Up ➤ Sign Up
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-002 Jul 31, 1992 ➤ Sign Up ➤ Sign Up
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-001 Jul 31, 1992 ➤ Sign Up ➤ Sign Up
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-003 Jul 31, 1992 ➤ Sign Up ➤ Sign Up
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-003 Jul 31, 1992 ➤ Sign Up ➤ Sign Up
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-001 Jul 31, 1992 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Teva
Chinese Patent Office
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.